How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News Pharma Industry News Can Allurion Technologies reset investor confidence with FDA momentum and a debt-free strategy? Allurion Technologies aims to bounce back with FDA milestones, a debt-free strategy, and new capital. Will this turnaround move the stock in 2025? bySrinathNovember 11, 2025